Back to Search
RADKO KOMERS, M.D.
M.D.
Internal Medicine Physician
NPI: 1417276544Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MF150676(OR)
Clinical Trials (1)
1
Linked Trials
1
Recruiting
0
With Results
Research & Publications (20)
Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
PMID 18022596·Transl Res·2007
7-preclinical
Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney.
PMID 16731827·Diabetes·2006
7-preclinical
Effects of long-term inhibition of neuronal nitric oxide synthase (NOS1) in uninephrectomized diabetic rats.
PMID 15491847·Nitric Oxide·2004
7-preclinical
Paradoxes of nitric oxide in the diabetic kidney.
PMID 12736164·Am J Physiol Renal Physiol·2003
6-review
Cyclooxygenase-2 expression and function in renal pathophysiology.
PMID 12683422·J Hypertens Suppl·2002
6-review
Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes.
PMID 12434137·J Lab Clin Med·2002
7-preclinical
Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.
PMID 11728945·Am J Kidney Dis·2001
6-review
Treatment of hypertension in diabetic patients with nephropathy.
PMID 12643207·Curr Diab Rep·2001
6-review
Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes.
PMID 11285308·J Clin Invest·2001
7-preclinical
Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes.
PMID 11060823·Expert Opin Investig Drugs·2000
6-review
Optimal strategies for preventing progression of renal disease: should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together?
PMID 10995522·Curr Hypertens Rep·2000
6-review
Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes.
PMID 10966937·Am J Physiol Renal Physiol·2000
7-preclinical
Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?
PMID 10757223·Curr Opin Nephrol Hypertens·2000
6-review
Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats.
PMID 10679513·Hypertension·2000
7-preclinical
Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.
PMID 15136972·J Renin Angiotensin Aldosterone Syst·2004
3-trial
Effect of ACE inhibition and angiotensin AT1 receptor blockade on renal and blood pressure response to L-arginine in humans.
PMID 10678543·J Hypertens·2000
3-trial
Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
PMID 19473197·Clin Exp Pharmacol Physiol·2010
7-preclinical
Determination of caveolin-1 in renal caveolar and non-caveolar fractions in experimental type 1 diabetes.
PMID 18657009·Physiol Res·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD, OREGON HEALTH & SCIENCCE UNIVERSITY, NEPHROLOGY, PP262
PORTLAND, OR 97239 - Phone
- (503) 494-8490
Quick Facts
- NPI
- 1417276544
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile